Andrew Ambrosy to Respiratory Tract Infections
This is a "connection" page, showing publications Andrew Ambrosy has written about Respiratory Tract Infections.
Connection Strength
0.186
-
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
Score: 0.186